ETON — Eton Pharmaceuticals Inc. price, chart and key statistics

Price data

Price

$50.19

YTD price return

+196.81%

YTD total return

+196.81%

Next earnings

Nov 5, 2026

Market cap

1.4B2018-12 107.9M2026-10 1.4B+1229.8% over the window

Enterprise value

1.4B

Shares outstanding

28.6M2018-09 17.6M2026-06 28.6M+62.3% over the window

52W low

$14.27

52W high

$66.37

From 52W high

-24.38%

From 52W low

+251.72%

52W range

69%

Volume

Rel volume

0.57×

30D volume

551.2K

30D $ vol

30.2M

Fundamentals

Sales (ttm)

105.6M2019-12 959K2026-06 105.6M+10910.9% over the window

Sales/share

$3.692019-12 $0.052026-06 $3.69+6788.8% over the window

EPS (ttm)

$0.392020-03 -$1.102026-06 $0.39-135.2% over the window

FCF (ttm)

14.7M2019-12 -19.1M2026-06 14.7M-177.0% over the window

FCF/share

$0.522019-12 -$1.072026-06 $0.52-148.2% over the window

Book value/share

$1.632018-09 -$0.932026-06 $1.63-274.9% over the window

Net margin

12.02%2019-12 -1910.3%2026-06 12.0%-100.6% over the window

ROE

27.24%2019-06 -103.6%2026-06 27.2%-126.3% over the window

ROA

10.96%2019-06 -94.8%2026-06 11.0%-111.6% over the window

Debt / equity

0.41×2019-12 0.432026-06 0.41-4.8% over the window

Current ratio

1.522018-09 5.682026-06 1.52-73.3% over the window

Growth (CAGR, ttm) · 10Y

Sales

+81.57%2025-06-30 → 2026-06-3058.2M → 105.6M (+81.5% total)+53.80%2023-06-30 → 2026-06-3029M → 105.6M (+263.9% total)+47.98%2021-06-30 → 2026-06-3014.9M → 105.6M (+609.5% total)n/a

FCF

+20.53%2025-06-30 → 2026-06-3012.2M → 14.7M (+20.5% total)+30.16%2023-06-30 → 2026-06-306.7M → 14.7M (+120.5% total)n/an/a

Shares

+6.59%2025-06-30 → 2026-06-3026.8M → 28.6M (+6.6% total)+3.67%2023-06-30 → 2026-06-3025.7M → 28.6M (+11.4% total)+3.05%2021-06-30 → 2026-06-3024.6M → 28.6M (+16.2% total)n/a

Per-share growth (CAGR, ttm) · 10Y

Sales/share

+70.35%2025-06-30 → 2026-06-30$2.17 → $3.69 (+70.3% total)+48.35%2023-06-30 → 2026-06-30$1.13 → $3.69 (+226.6% total)+43.61%2021-06-30 → 2026-06-30$0.61 → $3.69 (+510.6% total)n/a

FCF/share

+13.08%2025-06-30 → 2026-06-30$0.46 → $0.52 (+13.1% total)+25.55%2023-06-30 → 2026-06-30$0.26 → $0.52 (+97.9% total)n/an/a

Book value/share

+82.49%2025-06-30 → 2026-06-30$0.89 → $1.63 (+82.4% total)+35.71%2023-06-30 → 2026-06-30$0.65 → $1.63 (+150.0% total)+14.10%2021-06-30 → 2026-06-30$0.84 → $1.63 (+93.4% total)n/a

Price

+172.96%2025-10-20 → 2026-10-20$18.40 → $50.19 (+172.8% total)Price appreciation from split-adjusted daily closes, excluding dividends; endpoints are exact trading-day anniversaries of the latest close.+134.90%2023-10-20 → 2026-10-20$3.87 → $50.19 (+1196.9% total)Price appreciation from split-adjusted daily closes, excluding dividends; endpoints are exact trading-day anniversaries of the latest close.+55.57%2021-10-20 → 2026-10-20$5.51 → $50.19 (+810.9% total)Price appreciation from split-adjusted daily closes, excluding dividends; endpoints are exact trading-day anniversaries of the latest close.n/a

Total return

+172.96%2025-10-20 → 2026-10-20$18.40 → $50.19 (+172.8% total)Total return with dividends reinvested (adjusted daily closes); endpoints are exact trading-day anniversaries of the latest close. The gap against the Price row is the dividend contribution.+134.90%2023-10-20 → 2026-10-20$3.87 → $50.19 (+1196.9% total)Total return with dividends reinvested (adjusted daily closes); endpoints are exact trading-day anniversaries of the latest close. The gap against the Price row is the dividend contribution.+55.57%2021-10-20 → 2026-10-20$5.51 → $50.19 (+810.9% total)Total return with dividends reinvested (adjusted daily closes); endpoints are exact trading-day anniversaries of the latest close. The gap against the Price row is the dividend contribution.n/a

Fundamentals end at the last reported quarter; price and total return end at the latest close.

Valuation

P/E (ttm)Price ÷ TTM diluted EPS. Net income carries everything below the operating line, including one-off gains. Negative when the trailing year lost money.

129.7×2019-09 -5.812026-10 113.07-2044.4% over the window

Fwd P/E

19.7×

P/S (ttm)Market cap ÷ TTM revenue.

13.6×2019-12 134.262026-10 13.59-89.9% over the window

P/B (mrq)Market cap ÷ stockholders' equity at the most recent quarter end.

30.8×2018-12 4.102026-10 30.80+650.8% over the window

P/FCF (ttm)Market cap ÷ TTM free cash flow (operating cash flow − capex).

97.4×2019-12 -6.732026-10 97.38-1546.2% over the window

EV/EBITDA (fy)

68.9×

EV/Sales (ttm)

13.6×

FCF yield (ttm)TTM free cash flow ÷ market cap — the inverse of P/FCF.

1.03%2019-12 -14.9%2026-06 1.4%-109.6% over the window

Buyback yield (realized, 1y)1 − shares_at(2026-06-30) ÷ shares_at(2025-06-30) = 1 − 28.6M ÷ 26.8M. Point-in-time share counts from the company's own SEC filings (the same count at both ends), published only when the cash flow statement shows repurchases inside that window. A falling price can't inflate it; negative means net dilution.

-6.59%

Shareholder yield (realized, 1y)Buyback leg + dividend leg: shares retired over the year (-6.59%) + dividends paid over that year ($0) ÷ market_cap_at(2025-06-30) ($382.1M). Both legs are measured against the start of the window, so a payout can't shrink its own denominator.

-6.59%

Buyback yield (cash, ttm)Buybacks net of issuance over the trailing twelve months ($0) ÷ today's market cap ($1.4B). Dollars SPENT over what the company is worth NOW — a stock that fell after buying reads high.

0.00%2019-12 0.0%2026-06 0.0%

Shareholder yield (cash, ttm)(TTM buybacks net of issuance $0 + TTM dividends $0) ÷ today's market cap ($1.4B). Same caveat as the cash buyback yield.

0.00%2019-12 0.0%2026-06 0.0%

Vs own 10Y history

P/S

76th

P/B

94th

P/FCF

76th